Breaking News Instant updates and real-time market news.

PRGO

Perrigo

$43.60

-1.33 (-2.96%)

10:41
01/09/19
01/09
10:41
01/09/19
10:41

Perrigo CEO says 'substantial interest' seen in Rx unit, Dealreporter reports

Perrigo CEO Murray Kessler said in an interview after a presentation to the JPMorgan Healthcare Conference that the company, which previously disclosed that its board had approved a plan to separate its pharmaceuticals business, is receiving "substantial interest" from both financial and strategic buyers for its prescription pharmaceuticals division, reported Dealreporter, according to contacts. Kessler added that he hopes to update the market on the process at an analyst meeting in April, noting that the company is "prioritizing a sale over a spin-off," said Dealreporter, according to contacts.

PRGO Perrigo
$43.60

-1.33 (-2.96%)

11/13/18
11/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lumentum (LITE) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying yesterday's negative pronouncement underscored the challenges likely to be faced by Apple (AAPL) supply chain companies in delivering to investor expectations as Apple continues to prioritize its premium pricing strategy on iPhones relative to volumes. 2. Best Buy (BBY) downgraded to Neutral from Buy at BofA/Merrill with analyst Curtis Nagle citing expectations for slowing industry growth, difficult comps in key products and cost inflation. 3. Perrigo (PRGO) downgraded to Hold from Buy at Berenberg with analyst Patrick Trucchio saying although the key reason to own Perrigo shares remains intact, namely the U.S. government's push to shift more products from prescription to nonprescription, "too much uncertainty in generics has placed us on the sidelines." 4. Sabra Health Care (SBRA) downgraded to Neutral from Buy at Mizuho with analyst Richard Anderson saying he wants to a take a "pause" until the earnings reset from the "surprise news" of Senior Care stopping rent payments since May becomes better understood. 5. Infinera (INFN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Meta Marshall saying she sees "no reason to race in" until there are signs that the revenue base has stabilized. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/14/18
WELS
11/14/18
NO CHANGE
Target $64
WELS
Market Perform
Perrigo price target lowered to $64 form $77 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target for Perrigo to $64 from $77 following quarterly results. The analyst reiterates a Market Perform rating on the shares.
11/28/18
11/28/18
NO CHANGE

Perrigo reaches settlement in Sernivo patent litigation case
Perrigo has settled its Hatch-Waxman litigation relating to Sernivo Spray brought by Promius Pharma. Terms of the settlement are confidential. Sernivo Spray is indicated for the treatment of mild-to-moderate plaque psoriasis in patients 18 years of age or older. Annual market sales for the 12 months ending September 2018 were approximately $13M.
12/21/18
CANT
12/21/18
NO CHANGE
Target $107
CANT
Overweight
Cantor Fitzgerald says don't read too much into Perrigo tax headlines
Cantor Fitzgerald analyst Louise Chen tells investors not to read too much into the headlines from Perrigo last night regarding an Irish corporation tax liability. In a research note titled "Bah-Humbug, Don't Let Headlines Ruin The Holidays," Chen says it is "unclear that there is much of a case here." The analyst keeps an Overweight rating on Perrigo with a $107 price target.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$320.99

-14.02 (-4.18%)

16:39
02/21/19
02/21
16:39
02/21/19
16:39
Downgrade
Biogen rating change  »

Biogen downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 28

    May

GMED

Globus Medical

$47.68

0.05 (0.10%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Earnings
Globus Medical reports Q4 EPS 43c, consensus 39c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 06

    Mar

CASA

Casa Systems

$11.96

-0.02 (-0.17%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Earnings
Casa Systems sees FY19 EPS 30c-40c, consensus 73c »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

REGN

Regeneron

$418.66

-3.9 (-0.92%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Downgrade
Regeneron rating change  »

Regeneron downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 11

    Mar

  • 11

    Mar

  • 28

    Apr

  • 13

    May

MBIN

Merchants Bancorp

$21.92

-0.08 (-0.36%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Hot Stocks
Merchants Bancorp raises quarterly dividend 17% to 7c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HF

HFF Inc.

$42.40

-0.26 (-0.61%)

16:38
02/21/19
02/21
16:38
02/21/19
16:38
Earnings
HFF Inc. reports Q4 EPS $1.11, consensus $1.04 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HASI

Hannon Armstrong

$23.67

0.16 (0.68%)

16:37
02/21/19
02/21
16:37
02/21/19
16:37
Hot Stocks
Hannon Armstrong announces changes on leadership team »

Hannon Armstrong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

SEM

Select Medical

$15.49

-0.11 (-0.71%)

16:37
02/21/19
02/21
16:37
02/21/19
16:37
Earnings
Select Medical backs FY19 EPS view 97c-$1.13, consensus $1.10 »

Backs FY19 revenue view…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

BOOM

DMC Global

$35.37

0.04 (0.11%)

16:37
02/21/19
02/21
16:37
02/21/19
16:37
Earnings
Breaking Earnings news story on DMC Global »

DMC Global sees Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

BIDU

Baidu

$171.72

0.64 (0.37%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Hot Stocks
Baidu reports Baidu App DAUs reach 161M in December, up 24% y/y »

Baidu App daily active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 20

    Mar

CPB

Campbell Soup

$35.44

0.26 (0.74%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Hot Stocks
Campell Soup to sell Campbell Fresh Plant to JGC affiliate »

Campbell Soup announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    May

MGM

MGM Resorts

$28.34

-0.48 (-1.67%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Hot Stocks
MGM reaffirms previously announced 2020 free cash flow targets »

MGM Resorts reaffirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

CASA

Casa Systems

$11.96

-0.02 (-0.17%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Earnings
Casa Systems reports Q4 EPS 20c, consensus 14c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

BOOM

DMC Global

$35.37

0.04 (0.11%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Earnings
DMC Global reports Q4 EPS 46c, consensus 36c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Mar

WRB

W. R. Berkley

$82.37

-0.16 (-0.19%)

16:36
02/21/19
02/21
16:36
02/21/19
16:36
Hot Stocks
W. R. Berkley announces 3-for-2 stock split »

W. R. Berkley announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:35
02/21/19
02/21
16:35
02/21/19
16:35
General news
Fed Balance Sheet Level data reported »

Week of 2/20 Fed Balance…

16:35
02/21/19
02/21
16:35
02/21/19
16:35
General news
Money Supply M2 Weekly Change data reported »

Week of 2/11 Money Supply…

16:35
02/21/19
02/21
16:35
02/21/19
16:35
General news
Quarterly Services Report (Advance) Information Revenue data reported »

Quarterly Services Report…

16:35
02/21/19
02/21
16:35
02/21/19
16:35
General news
Quarterly Services Report (Advance) Information Revenue data reported »

Quarterly Services Report…

MGM

MGM Resorts

$28.34

-0.48 (-1.67%)

16:35
02/21/19
02/21
16:35
02/21/19
16:35
Hot Stocks
MGM announces resignation of CFO Dan D'Arrigo, appoints Corey Sanders to role »

MGM Resorts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

SUNS

Solar Senior Capital

$16.81

0.05 (0.30%)

16:35
02/21/19
02/21
16:35
02/21/19
16:35
Earnings
Solar Senior Capital reports Q4 NII 35c, consensus 35c »

At December 31, 2018, net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

OPNT

Opiant Pharmaceuticals

$14.65

-0.25 (-1.68%)

16:35
02/21/19
02/21
16:35
02/21/19
16:35
Hot Stocks
Breaking Hot Stocks news story on Opiant Pharmaceuticals »

Opiant Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HASI

Hannon Armstrong

$23.67

0.16 (0.68%)

16:34
02/21/19
02/21
16:34
02/21/19
16:34
Hot Stocks
Hannon Armstrong confirms 2018-2020 guidance »

The Company is confirming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

BIDU

Baidu

$171.72

0.64 (0.37%)

16:34
02/21/19
02/21
16:34
02/21/19
16:34
Hot Stocks
Baidu CEO says 'we are excited to enter the new year on strong footing' »

"We are excited to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 20

    Mar

TGH

Textainer

$13.05

-0.06 (-0.46%)

16:34
02/21/19
02/21
16:34
02/21/19
16:34
Earnings
Textainer reports Q4 EPS 21c, consensus 35c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.